This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Aconcagua Bio, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Eric Therrien: Innovator in Pharmaceutical Compounds
Introduction
Eric Therrien is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptor activities.
Latest Patents
Eric Therrien holds 1 patent for his work titled "Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity." This patent provides innovative compounds for modulating calcitonin receptor and/or amylin receptor activity. The disclosure also includes pharmaceutical compositions comprising these compounds, along with methods for treating diseases or disorders associated with these receptors.
Career Highlights
Eric is currently associated with Aconcagua Bio, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for patients suffering from conditions linked to receptor activity.
Collaborations
Eric collaborates with talented individuals in his field, including Hui Lei and Cui Li. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Eric Therrien is a dedicated inventor whose work in pharmaceutical compounds is making a significant impact in the medical field. His contributions are paving the way for new treatments and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile